US FDA approves KalVista Pharma's swelling disorder drug, shares rise

Related
Aehr Test Systems falls 19% postmarket following quarterly r...
7 minutes ago
0
Gold ETFs amassed largest inflow in five years during H1, Wo...
12 minutes ago
0
Pembina Pipeline Corporation 5.2% CUM PFD 25 declares CAD 0....
15 minutes ago
0
Pembina Pipeline Corporation PFD CL A SER 15 declares CAD 0....
16 minutes ago
0
Pembina Pipeline Corporation PFD CL A SER 9 declares CAD 0.2...
17 minutes ago
0
Emergent BioSolutions signs contract modification award for ...
25 minutes ago
0
Macron says France and the UK will ‘save Europe’ even though...
35 minutes ago
0
Citi to expand in North Carolina, adding 510 jobs in Charlot...
36 minutes ago
0
Emergent Biosolutions secures $51.9M contract modification a...
38 minutes ago
0
Bank of Montreal 3.8% PFD 33 CL B declares $0.1909 dividend
38 minutes ago
0
Apple places supply chain strategist in chief operating offi...
40 minutes ago
0
Mobileye Q2 guidance range above consensus
43 minutes ago
0
Toll Brothers partners with International Capital to develop...
58 minutes ago
0
RxSight stock slides on lower Q2 revenue guidance
1 hour ago
0
Nasdaq's U.S. matched equity volume edges up in June
1 hour ago
0
Trending
Popular
© FBT Company 2025. All rights are reserved